364 related articles for article (PubMed ID: 16369332)
21. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
[TBL] [Abstract][Full Text] [Related]
22. Anti-IgE for chronic asthma in adults and children.
Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
Cochrane Database Syst Rev; 2004; (3):CD003559. PubMed ID: 15266491
[TBL] [Abstract][Full Text] [Related]
23. Omalizumab and the treatment of allergic rhinitis.
Kaliner MA
Curr Allergy Asthma Rep; 2004 May; 4(3):237-44. PubMed ID: 15056407
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma.
Ayres JG; Higgins B; Chilvers ER; Ayre G; Blogg M; Fox H
Allergy; 2004 Jul; 59(7):701-8. PubMed ID: 15180756
[TBL] [Abstract][Full Text] [Related]
25. Omalizumab.
Easthope S; Jarvis B
Drugs; 2001; 61(2):253-60; discussion 261. PubMed ID: 11270941
[TBL] [Abstract][Full Text] [Related]
26. Anti-immunoglobulin E (omalizumab) therapy in allergic asthma.
Busse WW
Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 2):S12-7. PubMed ID: 11704612
[TBL] [Abstract][Full Text] [Related]
27. Omalizumab: a novel therapy for allergic asthma.
Davis LA
Ann Pharmacother; 2004; 38(7-8):1236-42. PubMed ID: 15187202
[TBL] [Abstract][Full Text] [Related]
28. Anti-IgE antibodies for the treatment of asthma.
Buhl R
Curr Opin Pulm Med; 2005 Jan; 11(1):27-34. PubMed ID: 15591885
[TBL] [Abstract][Full Text] [Related]
29. Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases.
D'Amato G; Oldani V; Donner CF
Monaldi Arch Chest Dis; 2003; 59(1):25-9. PubMed ID: 14533279
[TBL] [Abstract][Full Text] [Related]
30. Anti-IgE for chronic asthma.
Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
Cochrane Database Syst Rev; 2003; (3):CD003559. PubMed ID: 12917972
[TBL] [Abstract][Full Text] [Related]
31. Omalizumab: a review of its use in the management of allergic asthma.
Bang LM; Plosker GL
Treat Respir Med; 2004; 3(3):183-99. PubMed ID: 15219177
[TBL] [Abstract][Full Text] [Related]
32. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis.
Adelroth E; Rak S; Haahtela T; Aasand G; Rosenhall L; Zetterstrom O; Byrne A; Champain K; Thirlwell J; Cioppa GD; Sandström T
J Allergy Clin Immunol; 2000 Aug; 106(2):253-9. PubMed ID: 10932067
[TBL] [Abstract][Full Text] [Related]
33. Experience with monoclonal antibodies in allergic mediated disease: seasonal allergic rhinitis.
Casale TB
J Allergy Clin Immunol; 2001 Aug; 108(2 Suppl):S84-8. PubMed ID: 11498678
[TBL] [Abstract][Full Text] [Related]
34. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
[TBL] [Abstract][Full Text] [Related]
35. Omalizumab for asthma in adults and children.
Normansell R; Walker S; Milan SJ; Walters EH; Nair P
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003559. PubMed ID: 24414989
[TBL] [Abstract][Full Text] [Related]
36. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
Busse W; Corren J; Lanier BQ; McAlary M; Fowler-Taylor A; Cioppa GD; van As A; Gupta N
J Allergy Clin Immunol; 2001 Aug; 108(2):184-90. PubMed ID: 11496232
[TBL] [Abstract][Full Text] [Related]
37. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.
Casale TB; Condemi J; LaForce C; Nayak A; Rowe M; Watrous M; McAlary M; Fowler-Taylor A; Racine A; Gupta N; Fick R; Della Cioppa G;
JAMA; 2001 Dec; 286(23):2956-67. PubMed ID: 11743836
[TBL] [Abstract][Full Text] [Related]
38. Omalizumab (Xolair): an anti-IgE antibody for asthma.
Med Lett Drugs Ther; 2003 Aug; 45(1163):67-8. PubMed ID: 12915804
[No Abstract] [Full Text] [Related]
39. Targeting immunoglobulin E as a novel treatment for asthma.
Sandström T
Curr Allergy Asthma Rep; 2005 Mar; 5(2):109-15. PubMed ID: 15683610
[TBL] [Abstract][Full Text] [Related]
40. Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis.
Casale TB;
Drugs Today (Barc); 2004 Apr; 40(4):367-76. PubMed ID: 15190389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]